This meta-analysis comprehensively evaluated the efficacy of three main categories of proinflammatory interleukin-1 direct therapeutics, including IL-1 receptor antagonists, anti-IL-1 antibodies and IL-1 inhibitors, in patients with knee osteoarthritis. This evidence concerns the gene IL1B and osteoarthritis, knee.